VIM and cancer: Vimentin is mainly expressed in cells of mesenchymal origin and has been described as a marker of epithelial-to-mesenchymal transition, which is a phenomenon related to increased invasiveness and resistance of some cancer cells, thus manifesting the progression of cancer [60,61].